Most Shorted Stocks
TEM is part of our most shorted stocks screen list, indicating it has a high short interest.
TEMPUS AI INC-CL A (TEM) Stock Price & Overview
NASDAQ:TEM • US88023B1035
Current stock price
55 USD
-0.48 (-0.87%)
At close:
55 USD
0 (0%)
After Hours:
The current stock price of TEM is 55 USD. Today TEM is down by -0.87%. In the past month the price increased by 16.06%. In the past year, price decreased by -3.61%.
TEM Key Statistics
52-Week Range41.73 - 104.32
Current TEM stock price positioned within its 52-week range.
1-Month Range42.41 - 58.04
Current TEM stock price positioned within its 1-month range.
- Market Cap
- 9.867B
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -0.61
- Dividend Yield
- N/A
TEM Stock Performance
Today
-0.87%
1 Week
+5.53%
1 Month
+16.06%
3 Months
-8.06%
Longer-term
6 Months -38.79%
1 Year -3.61%
2 Years N/A
3 Years N/A
5 Years N/A
10 Years N/A
TEM Stock Chart
TEM Stock Screens
TEM currently appears in the following ChartMill screener lists.
TEM Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to TEM. When comparing the yearly performance of all stocks, TEM is a bad performer in the overall market: 76.9% of all stocks are doing better.
Chartmill TA Rating
Chartmill Setup Rating
TEM Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to TEM. TEM has a bad profitability rating. Also its financial health evaluation is rather negative.
Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
TEM Earnings
On February 24, 2026 TEM reported an EPS of -0.04 and a revenue of 367.21M. The company beat EPS expectations (5.3% surprise) and beat revenue expectations (0.36% surprise).
Next Earnings DateMay 5, 2026
Last Earnings DateFeb 24, 2026
PeriodQ4 / 2025
EPS Reported-$0.04
Revenue Reported367.211M
EPS Surprise 5.30%
Revenue Surprise 0.36%
TEM Forecast & Estimates
23 analysts have analysed TEM and the average price target is 81.05 USD. This implies a price increase of 47.36% is expected in the next year compared to the current price of 55.
For the next year, analysts expect an EPS growth of 30.29% and a revenue growth 25.72% for TEM
Analysts
Analysts77.39
Price Target81.05 (47.36%)
EPS Next Y30.29%
Revenue Next Year25.72%
TEM Index Membership
TEM is currently included in the following stock indexes tracked on ChartMill.
TEM Financial Highlights
Over the last trailing twelve months TEM reported a non-GAAP Earnings per Share(EPS) of -0.61. The EPS increased by 75.89% compared to the year before.
Income Statements
Revenue(TTM)1.27B
Net Income(TTM)-245.03M
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -10.77% | ||
| ROE | -49.87% | ||
| Debt/Equity | 2.52 |
Chartmill High Growth Momentum
EPS Q2Q%77.78%
Sales Q2Q%82.98%
EPS 1Y (TTM)75.89%
Revenue 1Y (TTM)83.41%
TEM Ownership
Ownership
Inst Owners55.01%
Shares179.40M
Float109.09M
Ins Owners8.12%
Short Float %25.42%
Short Ratio5.2
TEM Industry Overview
TEM operates in the Life Sciences Tools & Services sub-industry within the Health Care sector. This group contains 51 stocks and is scored by ChartMill on both price strength and growth momentum.
Industry Strength Score
21/100
Composite price performance score based on 3, 6, and 12-month returns, with more weight on recent trends.
Industry Growth Score
50/100
Composite growth score based on earnings growth, revenue growth, and profitability across the sub-industry.
Relative Performance
Each rank shows how many other sub-industries were outperformed over that timeframe.
1 Month Rank
42%
Outperformed 42% of sub-industries
3 Month Rank
8%
Outperformed 8% of sub-industries
6 Month Rank
11%
Outperformed 11% of sub-industries
Industry Fundamentals & Breadth
- Members
- 51
- New Highs
- 0%
- New Lows
- 7.8%
- Average ROE
- 15%
- Average Profit Margin
- 15.8%
- Average Operating Margin
- 18.7%
- Average P/E
- 33.5
- Average Fwd P/E
- 28.8
- Average Debt/Equity
- 0.8
TEM Competitors/Peers
The largest stocks on the US markets in the "Life Sciences Tools & Services" sub-industry
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 17.32 | 177.991B | ||
| DHR | DANAHER CORP | 19.03 | 126.643B | ||
| BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 135.35 | 44.626B | ||
| A | AGILENT TECHNOLOGIES INC | 17.04 | 32.654B | ||
| WAT | WATERS CORP | 21.12 | 30.357B | ||
| IQV | IQVIA HOLDINGS INC | 12.3 | 26.586B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 26.98 | 25.851B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 33.45 | 21.45B | ||
| ILMN | ILLUMINA INC | 22.75 | 19.253B | ||
| MEDP | MEDPACE HOLDINGS INC | 21.57 | 11.957B | ||
| RVTY | REVVITY INC | 15.75 | 9.684B | ||
| TECH | BIO-TECHNE CORP | 24.77 | 8.655B |
Related stock screener links
View all stocks in the Life Sciences Tools & Services Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find more growth stocks the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About TEM
Company Profile
Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. The company is headquartered in Chicago, Illinois and currently employs 3,800 full-time employees. The company went IPO on 2025-05-30. The company offers AI-enabled precision medicine solutions to physicians to deliver personalized patient care and, in parallel, facilitates discovery, development and delivery of optimal therapeutics. The company provides three product lines: Genomics, Data and artificial intelligence applications (AI). The Genomics product line leverages its laboratories to provide next generation sequencing (NGS) diagnostics, polymerase chain reaction, profiling, molecular genotyping and other anatomic and molecular pathology testing. The data generated in its lab or ingested into its platform is structured and de-identified, prior to commercialization. Its AI Applications is focused on developing and providing diagnostics that are algorithmic in nature, implementing new software as a medical device, and building and deploying clinical decision support tools.
Company Info
IPO: 2025-05-30
TEMPUS AI INC-CL A
600 West Chicago Avenue, Suite 510
Chicago ILLINOIS US
Employees: 3800
Phone: 18335144187
TEMPUS AI INC-CL A / TEM FAQ
What does TEM do?
Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. The company is headquartered in Chicago, Illinois and currently employs 3,800 full-time employees. The company went IPO on 2025-05-30. The company offers AI-enabled precision medicine solutions to physicians to deliver personalized patient care and, in parallel, facilitates discovery, development and delivery of optimal therapeutics. The company provides three product lines: Genomics, Data and artificial intelligence applications (AI). The Genomics product line leverages its laboratories to provide next generation sequencing (NGS) diagnostics, polymerase chain reaction, profiling, molecular genotyping and other anatomic and molecular pathology testing. The data generated in its lab or ingested into its platform is structured and de-identified, prior to commercialization. Its AI Applications is focused on developing and providing diagnostics that are algorithmic in nature, implementing new software as a medical device, and building and deploying clinical decision support tools.
What is the stock price of TEMPUS AI INC-CL A today?
The current stock price of TEM is 55 USD. The price decreased by -0.87% in the last trading session.
Does TEMPUS AI INC-CL A pay dividends?
TEM does not pay a dividend.
What is the ChartMill rating of TEMPUS AI INC-CL A stock?
TEM has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
What is the expected growth for TEM stock?
The Revenue of TEMPUS AI INC-CL A (TEM) is expected to grow by 25.72% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
When does TEMPUS AI INC-CL A (TEM) report earnings?
TEMPUS AI INC-CL A (TEM) will report earnings on 2026-05-05.